Literature DB >> 20380643

Peptides for in vivo target-specific cancer imaging.

G Ferro-Flores1, F de M Ramírez, L Meléndez-Alafort, C L Santos-Cuevas.   

Abstract

Molecular imaging comprises non-invasive monitoring of functional and spatiotemporal processes at molecular and cellular levels in living systems. Advanced imaging techniques can monitor such processes. Peptide receptors over-expressed in tumours can be targeted by peptides conjugated to radionuclides, near-infrared fluorochromes, metallic nanoparticles or quantum dots for target-specific cancer imaging.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380643     DOI: 10.2174/138955710791112596

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  7 in total

Review 1.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

Review 2.  Radiolabeled bombesin derivatives for preclinical oncological imaging.

Authors:  Carolina de Aguiar Ferreira; Leonardo Lima Fuscaldi; Danyelle M Townsend; Domenico Rubello; André Luís Branco de Barros
Journal:  Biomed Pharmacother       Date:  2016-12-29       Impact factor: 6.529

Review 3.  Nanoparticle ligand presentation for targeting solid tumors.

Authors:  Jason T Duskey; Kevin G Rice
Journal:  AAPS PharmSciTech       Date:  2014-06-14       Impact factor: 3.246

Review 4.  More effective nanomedicines through particle design.

Authors:  Jin Wang; James D Byrne; Mary E Napier; Joseph M DeSimone
Journal:  Small       Date:  2011-06-22       Impact factor: 13.281

5.  Galactose substituted zinc phthalocyanines as near infrared fluorescence probes for liver cancer imaging.

Authors:  Feng Lv; Yanzhou Li; Bo Cao; Tianjun Liu
Journal:  J Mater Sci Mater Med       Date:  2012-11-27       Impact factor: 3.896

Review 6.  Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery.

Authors:  Zhi Jie Li; Chi Hin Cho
Journal:  J Transl Med       Date:  2012-09-19       Impact factor: 5.531

7.  Evaluation of (99m)Tc-HYNIC-βAla-Bombesin(7-14) as an agent for pancreas tumor detection in mice.

Authors:  F N Carlesso; L L Fuscaldi; R S Araújo; C S Teixeira; M C Oliveira; S O A Fernandes; G D Cassali; D C Reis; A L B Barros; V N Cardoso
Journal:  Braz J Med Biol Res       Date:  2015-05-19       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.